| ²é¿´: 445 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
µ¥¾äÇóÖú
|
|
| In summary, in recent years DLL4 has appeared as a significant regulator of tumor angiogenesis. Blockade of this ligand results in non-productive angiogenesis with an inhibitory effect on tumor growth. Nevertheless, the careful evaluation of adverse effects on physiology of normal organs in relation to therapeutic doses of DLL4 inhibitors will be critical for advancement of DLL4 blocking agents in clinical oncology. |
» ²ÂÄãϲ»¶
¼±Ðèµ÷¼Á
ÒѾÓÐ8È˻ظ´
É격/¿¼²©
ÒѾÓÐ4È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ37È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
260Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ç󲩵¼£üÉúÎïÖÊ»ù¶à¿×̼/³¬¼¶µçÈÝ·½Ïò£¬ÒÑÓÐÏà¹Ø³É¹û£¬Ñ°ÄÜÔ´²ÄÁÏ/̼²ÄÁÏ·½ÏòÀÏʦ
ÒѾÓÐ3È˻ظ´
¶þ±½¼×ͪËáÀàÑÜÉúÎï
ÒѾÓÐ6È˻ظ´
½ÓÊÜÈκε÷¼Á
ÒѾÓÐ4È˻ظ´

ÕŹúÓª2176
гæ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 144.9
- Ìû×Ó: 57
- ÔÚÏß: 15.9Сʱ
- ³æºÅ: 2441457
- ×¢²á: 2013-04-29
- רҵ: ¹Ç¡¢¹Ø½Ú¡¢Èí×éÖ¯ËðÉËÓëÐÞ
3Â¥2013-09-23 23:00:35
xux730
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 86
- Ó¦Öú: 1719 (½²Ê¦)
- ½ð±Ò: 10740.4
- É¢½ð: 50
- ºì»¨: 43
- Ìû×Ó: 2947
- ÔÚÏß: 336.5Сʱ
- ³æºÅ: 1374299
- ×¢²á: 2011-08-20
- רҵ: ϸ°ûÖÜÆÚÓëµ÷¿Ø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
yin198716: ½ð±Ò+5, ·ÒëEPI+1 2013-09-23 23:44:16
yin198716: ½ð±Ò+5, ·ÒëEPI+1 2013-09-23 23:44:16
| ×ÜÖ®£¬ÔÚ×î½ü¼¸ÄêÖÐDLL4Ã÷ÏÔ³ÉΪÖ×ÁöѪ¹ÜÉú³ÉµÄÒ»¸öÏÔÖøµ÷½ÚÒò×Ó¡£×è¶Ï¸ÃÅäÌåµ¼Ö¶ÔÖ×ÁöÉú³¤¾ßÓÐÒÖÖÆÐ§¹ûµÄÎÞЧѪ¹ÜÉú³É¡£È»¶ø£¬×ÐϸÆÀ¹ÀÖÎÁƼÁÁ¿µÄDLL4ÒÖÖÆ¼Á¶ÔÕý³£Æ÷¹ÙÉúÀíÉϵIJ»Á¼Ó°Ï콫ÊÇDLL4×è¶Ï¼ÁÔÚÁÙ´²Ö×ÁöѧȡµÃ½øÕ¹µÄ¹Ø¼ü¡£ |
2Â¥2013-09-23 22:04:15













»Ø¸´´ËÂ¥
50